Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in ...

Semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

In this week’s Bloom Boost – health news you might have missed, Gayle Guyardo , the host of the nationally syndicated health ...

Ozempic and Wegovy, made by Novo Nordisk, are now listed as available across all doses on the FDA’s drug shortage list. But ...

Semaglutide was linked to a significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs.

A clinical trial funded by Novo Nordisk found that Ozempic (semaglutide) was linked with reduced pain among patients with ...